BLIS Technologies Limited logo

Revenue Growth and Profitable Third Quarter

Guidance20 February 2025BLTConsumer Staples

21 February 2025
Revenue Growth and Profitable Third Quarter

For the third quarter ending 31 December 2024, Blis Technologies Limited (BLIS) delivered revenue

of $3.2m, being growth of 4% on the same period last year and a positive EBITDA result of $0.3m

(unaudited).

The nine months to 31 December 2024 saw revenue growth of 17% on the same period last year.

This revenue growth has predominantly come from a $0.9m (34%) increase in B2C revenue across

the Daigou, Amazon and webstore channels, with B2B channel delivering growth of $0.5m (8%)

growth.

“While the B2B channel remains the core pillar of the BLIS business, our B2C focus has been on

increasing profitability in existing channels. BLIS’ will continue to focus on winning in the right

markets with key business partners. This will allow us to leverage the increased consumer awareness

of the importance of maintaining a healthy oral microbiome for overall good health and wellbeing

and is driving them to seek out BLIS’ clinically proven probiotic solutions.” said Scott Johnson, CEO.

Based on the latest customer sales forecasts and market feedback, guidance is for full year revenue

to be in excess of $12m, with EBITDA in the range of $0.6m to $0.8m. This is a pleasing result given

the current tough economic environment and reinforces our commitment to delivering sustainable

profitability.


Ends


For further information, please contact:


Scott Johnson

CEO

+64 21 488 831


About Blis Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand

and in Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at

www.blis.co.nz.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.